Blood Pressure Medication Timing: Morning or Night?
Updated: 4 hours ago
The short answer
For your heart, the hour does not matter. The TIME trial randomly assigned 21,104 adults already on blood pressure medication to take everything in the morning or everything in the evening, and after a median of just over five years the two groups had the same rate of heart attacks, strokes, and cardiovascular deaths, 3.4 percent against 3.7 percent. So take your pills at the hour you will actually remember, because a skipped dose costs you more than the wrong hour ever will. The one timing rule that does hold is about side effects rather than events: take a water pill in the morning, or it will wake you up at night and cost you the sleep that helps keep your pressure down.
What we cover
Why high systolic blood pressure is the second largest contributor to global disease burden, and how it scars kidneys years before you feel anything. (The Lancet, 2024)
What the TIME trial found when 21,104 adults were randomly assigned to morning or evening dosing and followed for a median of just over five years. (The Lancet, 2022)
Why the earlier Hygia trial reported a benefit far larger than blood pressure treatment produces, and what the journal did about it. (European Heart Journal, 2020)
What the chronotype substudy hinted at, and why an exploratory finding is not a reason to change your dosing tonight. (eClinicalMedicine, 2024)
What SPRINT found when systolic pressure was pushed below 120 instead of below 140, and the harms that came with it. (New England Journal of Medicine, 2015)
Why below 120 in that trial is not the same as below 120 on your kitchen cuff, and which groups the trial left out.
Why the kidney-specific case for chasing a low number is weaker than the heart case, and what does protect kidneys over years.
The two numbers to ask for at your next visit, eGFR and the urine albumin-to-creatinine ratio, and why most offices run only the first.
Timestamps
00:00 The nighttime advice, and the 21,000-patient test
00:47 The answer first: what the TIME trial found
01:45 The results, and why the skipped dose is the real enemy
02:44 The Spanish study that claimed the opposite
03:38 One honest nuance: your body clock
04:56 The fact I held back: SPRINT and the number you live at
05:56 Two things to know before you chase that number
07:40 The two kidney numbers to ask for
09:06 The one real timing rule: your water pill
09:46 Your questions answered
11:17 The bottom line and your action items
References
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162-2203. https://doi.org/10.1016/S0140-6736(24)00933-4 (observational burden-of-disease estimate).
High systolic blood pressure was a major contributor to global disease burden. Evidence type: comparative risk analysis.
Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400(10361):1417-1425. https://doi.org/10.1016/S0140-6736(22)01786-X (randomized trial).
Evening dosing was no different from morning dosing for major cardiovascular outcomes: 3.4 percent against 3.7 percent, hazard ratio 0.95 (95% CI 0.83 to 1.10), in 21,104 adults over a median of 5.2 years.
Hermida RC, Crespo JJ, Dominguez-Sardina M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. European Heart Journal. 2020;41(48):4565-4576. https://doi.org/10.1093/eurheartj/ehz754 (randomized trial, subject to a published Expression of Concern).
This earlier trial reported a benefit from bedtime dosing so large that no blood pressure intervention produces it, and the journal issued a formal Expression of Concern in April 2020 (Eur Heart J. A subsequent investigation found no grounds for ethical or factual concern, but methodological criticism persists, and the larger TIME trial is the better guide.
Pigazzani F, Dyar KA, Morant SV, et al. Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study. eClinicalMedicine. 2024;72:102633. https://doi.org/10.1016/j.eclinm.2024.102633 (exploratory substudy, early evidence).
An exploratory substudy of TIME found a hint that aligning dose timing to a person's chronotype might affect non-fatal heart attack specifically.
SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine. 2015;373(22):2103-2116. https://doi.org/10.1056/NEJMoa1511939 (randomized trial).
Treating systolic pressure to below 120 rather than below 140 cut major cardiovascular events and all-cause death, hazard ratio 0.73 for death, with more hypotension, syncope, and acute kidney injury in the intensively treated group. Blood pressure was measured by automated office readings, which run lower than a standard office or home cuff, and the trial excluded people with diabetes or a prior stroke.
One study explained in plain language every week, with sources attached, plus the free kidney health guide: https://guides.selfprinciple.org/kidney
This content is for educational purposes only and is not medical advice. Always consult your healthcare provider for individual care. The views expressed are Dr. Sean Hashmi's own and do not represent his employer.
Never start, stop, or change the dose of any prescription medication without consulting your physician.
Comments